Mark is the head of our market-leading inward investment practice, which advises tech and life sciences companies on international expansion and M&A. He is also the founding partner of our Silicon Valley representative office. Mark sits on Taylor Wessing's executive board as head of clients and innovation and strives to ensure we are the most sector-focused and client-centric law firm in the world.

Mark has been with Taylor Wessing since 1999, and now leads a team which acts for many of North America's best-known technology and life sciences companies, including approximately a quarter of US-based unicorns. He is a specialist in cross-border and domestic M&A as well as tax-driven restructurings. Mark can guide clients looking to establish themselves, often for the first time, in Europe and Asia and often acts as an outsourced GC as they grow and expand. His team helps between 50 and 75 venture-backed US and Canadian corporations set up in Europe each year. Between 2014 and 2018, Mark founded and managed our Silicon Valley representative office. He returned to London in 2018.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising Cognism Limited on Kaspr acquisition

17 mai 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising Better in Property Partner acquisition to reimagine homeownership

15 septembre 2021

par plusieurs auteurs

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising Dataminr on its acquisition of WatchKeeper

15 juillet 2021

par Mark Barron et Ed Chapman

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising WuXi AppTec on acquisition of OXGENE to strengthen cell and gene therapy service

4 mars 2021

par plusieurs auteurs

Cliquer ici pour en savoir plus

Autres avocats qui pourraient vous intéresser